Morgan Stanley remains Overweight-rated on Danaher DHR as the company reenters the M&A market with the acquisition of X-Rite.
Morgan Stanley notes, "This morning, Danaher announced that it has entered an agreement to acquire X-Rite, Inc. XRIT for $5.55/share (10% premium to its 52w high), and including assumption of $145m of net debt, total EV is $625m. …Strategically, the deal looks consistent with DHR's previously communicated intentions to grow Product ID
via M&A, as well as increasing exposure to Industrial markets vs. Med-Tech. While the business is already operating at 26% EBITDA margins, there should be good overlap and synergy opportunities within the existing PID platform, especially with Esko Artwork."
DHR closed at $54.59 a share yesterday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in